CinCor Pharma Overview
Valuation check: CINC's PEG ratio is -17.28, below the sector sector average of -7.59.
Get informed when a big investor buys or sells
+ Follow-17.28
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
CinCor Pharma (CINC) currently reports a PEG ratio of -17.28. That is below the sector sector average of -7.59. Use the charts on this page to explore CinCor Pharma's PEG ratio history and peer comparisons.
CinCor Pharma's PEG ratio of -17.28 is lower than the its sector sector average of -7.59. That is roughly 127.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates CinCor Pharma's market price to a fundamental measure such as earnings, sales, or book value. At -17.28, CINC can look expensive or cheap only in context — versus its own history, growth rate, and sector peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -17.28, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -7.59. From there, open related valuation or income-statement pages for CinCor Pharma, and consider following CINC for alerts when major investors trade the stock.
